Recent Updates
Recently added Catalysts
AKBA Positive Sentiment

Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...

Monday, November 25, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Akebia Therapeutics will present at the 36th Annual Piper Sandler Healthcare Conference on December 3, 2024. CEO John Butler will participate in a Fireside Discussion during the event. The conference will be held in New York from December 3-5, and a webcast of the presentation will be available on Akebia's website for six months.
Price reaction · baseline $1.88 (2024-11-22 close) · clean, no other AKBA news in the window
day 0 close · peak
+2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Akebia Therapeutics is actively participating in a major healthcare conference.
  • The company aims to improve the lives of patients with kidney disease.
  • The CEO's involvement highlights leadership engagement with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+1%
120-day peak, hindsight
Typical move
8%
average across 4 past catalysts
Lead asset
ferric
Phase 3 · Anemia of Chronic Kidney Disease

Full Press Release Details

CAMBRIDGE, Mass. , Nov. 25, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA ), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler , Chief Executive Officer, will participate in a Fireside Discussion at the 36 th Annual Piper Sandler Healthcare Conference on Tuesday, December 3 rd at 10:30 AM EST .
A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 6 months following the conference.
The Piper Sandler Healthcare Conference will take place December 3-5, 2024 in New York .
About Akebia Therapeutics Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts . For more information, please visit our website at www.akebia.com , which does not form a part of this release.
Akebia Therapeutics Contact Mercedes Carrasco [email protected]

Frequently Asked Questions

When is Akebia Therapeutics presenting?

Akebia Therapeutics will present on December 3, 2024.

Who will represent Akebia at the conference?

CEO John Butler will participate in the Fireside Discussion.

Where is the Piper Sandler Healthcare Conference held?

The conference will take place in New York.

How long will the presentation be available online?

The webcast will be accessible for six months after the conference.

ShareAdd on Google
Tags: AKBA Viatris Investor Conferences Healthcare Akebia Therapeutics Piper Sandler healthcare conference kidney disease John Butler
Last updated: Nov 25, 2024

Biotech snapshot

Cash runway
$156M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ferricPhase 3
Anemia of Chronic Kidney Disease →

Catalyst track record

+1%
best trade around AKBA's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for AKBA.

See every catalyst's timing & PoA →